Total planned funding: $786,350,233
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $182,343,955 |
Zambia | $114,209,109 |
Kenya | $108,916,088 |
Tanzania | $82,820,896 |
Uganda | $73,049,194 |
Mozambique | $54,359,195 |
Zimbabwe | $40,047,337 |
Rwanda | $30,164,897 |
Haiti | $23,541,731 |
Côte d'Ivoire | $18,824,046 |
Vietnam | $18,198,765 |
Democratic Republic of the Congo | $16,952,681 |
Cameroon | $10,027,160 |
Eswatini | $6,142,172 |
Ukraine | $2,605,290 |
Botswana | $1,637,678 |
South Africa | $1,065,492 |
Burundi | $696,834 |
Guyana | $500,000 |
South Sudan | $112,025 |
Ethiopia | $40,918 |
Papua New Guinea | $35,833 |
Central Asia Region | $33,169 |
India | $23,477 |
Caribbean Region | $2,291 |
Organizational Types
Private Contractor | $651,624,595 |
Host Country Government Agency | $66,458,634 |
NGO | $53,983,823 |
Unknown | $10,310,960 |
Own Agency | $3,066,008 |
Implementing Agency | $906,213 |
University | $0 |
FBO | $0 |
Program Areas
Treatment | $786,350,233 |
Budget Codes
HTXD: Treatment: ARV Drugs | $786,350,233 |
Top Partner Programs
Chemonics International:
$358,422,586
View countries
Kenya Medical Supplies Agency:
$66,386,810
View countries
Medical Access Uganda Limited:
$53,878,823
View countries